AMIORG vs BETA: Stock Comparison

AMIORG vs Beta Drugs Ltd

Live data: 30 May 2025, 4:01 PM IST • Source: NSE and company filings

AMIORG is the larger company by market capitalisation. AMIORG shows a lower P/E, a higher dividend yield and lower leverage, while Beta Drugs Ltd shows a higher ROE and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of AMIORG and Beta Drugs Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AMIORG is more favourable on 7 of 13 scored metrics and BETA on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
AMIORG is the larger company
₹26,850 Cr vs ₹2,558 Cr
P/E Ratio
AMIORG has a lower P/E
43.06x vs 57.18x
P/B Ratio
AMIORG has a lower P/B
6.82x vs 9.69x
EPS
BETA has higher earnings per share
₹40.9 vs ₹0
Dividend Yield
AMIORG has a higher dividend yield
0.04% vs 0%
Qtr Sales Growth
BETA has stronger quarterly sales growth
0.21% vs 0%
Qtr Profit Growth
AMIORG has stronger quarterly profit growth
0% vs -15.2%
ROE
BETA has a higher ROE
18.8% vs 12.15%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricAMIORGBETA
Live Price₹1,176.3₹2,315.6
Day Change-0.31%1.69%
Volume2.43 L19,164
52-Week High₹1,194.2₹2,674
52-Week Low₹1,170.1₹990.1
Distance from 52W High-1.5%-13.4%

Valuation

MetricAMIORGBETA
Market Cap₹26,850 Cr₹2,558 Cr
P/E Ratio43.06x57.18x
P/B Ratio6.82x9.69x
EPS₹0₹40.9
Book Value₹0₹241
Dividend Yield0.04%0%

Growth

MetricAMIORGBETA
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%0.21%
Qtr Profit Growth0%-15.2%

Profitability & Leverage

MetricAMIORGBETA
ROE12.15%18.8%
ROCE0%19.2%
Net Margin15.93%10.78%
Operating Margin22.09%19.7%
Debt to Equity0.01x0.6x

Shareholding

As of Sep 2025 • change vs previous quarter
MetricAMIORGBETA
Promoter Holding0.33% 32.33 pp59.1% 5.53 pp
FII Holding0.17% 16.77 pp1.02% 0.14 pp
DII Holding0.23% 22.15 pp6.23% 4.08 pp
Public Holding0.28% 27.73 pp33.65% 1.59 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AMIORG and Beta Drugs Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.